Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP7 | O15540 | 1/20 | 0.47 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6054965 | 0.86 | TDP1 (0.64) | FABP7FABP5TDP1ATMLMNA | |
| SCHEMBL1539164 | 0.85 | L3MBTL1 (0.47) | TDP1ATMLMNAADRA2ACNR1 | |
| SCHEMBL472949 | 0.85 | TDP1 (0.58) | FABP7FABP5TDP1ATMLMNA | |
| SCHEMBL3731260 | 0.82 | HTR2A (0.47) | TDP1ATMLMNAALDH1A1HTT | |
| SCHEMBL2128100 | 0.80 | FABP7 (0.48) | FABP7FABP5ATMALDH1A1HTT | |
| SCHEMBL6669213 | 0.76 | TDP1 (0.61) | FABP7FABP5TDP1ATMLMNA | |
| SCHEMBL1539179 | 0.75 | TDP1 (0.80) | TDP1ATMLMNAADRA2ACNR1 | |
| SCHEMBL28976430 | 0.74 | FABP7 (0.48) | FABP7FABP5ALDH1A1HTTMIF | |
| SCHEMBL2128089 | 0.74 | FABP7 (0.48) | FABP7FABP5ALDH1A1HTTMIF | |
| SCHEMBL7799337 | 0.74 | TDP1 (0.42) | FABP7FABP5TDP1ATMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1535895-B1 | PROCESS FOR PRODUCTION OF FORMYLCYCLOPROPANECARBOXYLIC ESTERS | SUMITOMO CHEMICAL CO (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-20050240050-A1 | Process for production of formylcyclopropanecarboxylic ester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-10-27 | — | — | US | disclosed |
| EP-1535895-A1 | PROCESS FOR PRODUCTION OF FORMYLCYCLOPROPANECARBOXYLIC ESTERS | Sumitomo Chemical Company, Limited (JP) | 2005-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240050-A1 | Process for production of formylcyclopropanecarboxylic ester | AHCYL1, HACL2, CBR1 | FABP7 1553/4885FABP5 1789/4885TDP1 4597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.